| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.069 | 0.1 |